[1]
2024. Retrospective analysis on the efficacy of the use of tocilizumab in patients with severe pneumonia due to SARS-CoV-2. Actualizaciones en Sida e Infectología. 32, 115 (Jul. 2024). DOI:https://doi.org/10.52226/revista.v32i115.274.